Home » Topics » BioWorld Science

BioWorld Science
RSS

Cellenkos and University of Texas enter neuroinflammation research collaboration

June 25, 2018

J-TEC signs license agreement for low-cost manufacturing technology of CAR-T cells

June 25, 2018

FDA clears IND for pivotal trial of INP-104 for acute treatment of migraine

June 25, 2018

Prefusion F protein respiratory syncytial virus vaccine DS-Cav1 safe in first-in-human study

June 25, 2018

YH-25448 demonstrates promising antitumor activity in patients with EGFR T790M-positive NSCLC

June 25, 2018

Erytech refocuses development efforts with eryaspase

June 25, 2018

IMpower133 study of Tecentriq in extensive stage SCLC meets coprimary endpoints

June 25, 2018

City of Hope studies memory-enriched T cells in recurrent or refractory glioma

June 25, 2018

Ohara Pharmaceutical obtains certain rights to compound from PRISM Pharma

June 25, 2018

FDA awards orphan drug designation to PCS-499 for necrobiosis lipoidica

June 25, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 30, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...